Testing a new oral medicine in healthy men
Part of Hormones & metabolism, Lungs & breathing clinical trials.
This study tests a new oral medication in healthy men to see how the body absorbs, processes, and eliminates it. It's an early step to determine safety and dosing, and you would be closely monitored.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male between 18 and 65 years old.
- Your body mass index (BMI) is between 18 and 32 kg/m² and you weigh at least 45 kg.
- You are in good general health with no major medical conditions (like heart, liver, kidney, or mental health issues).
- You do not smoke (or quit more than 3 months ago) and do not use nicotine products.
- You are not taking any prescription medications, over-the-counter drugs, vitamins, or herbal supplements.
- You agree to use highly effective contraception (or abstain from sex) from the start of the study until 90 days after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called SV001 in healthy volunteers to see if it is safe and how the body handles it. It is a first-in-human trial, meaning this drug has not been tested in people before.
This study tests a new oral medication called ACCG-2671 to see how safe it is and how your body handles it. It's an early-stage trial, so the main focus is on safety and tolerability. The study has different parts: one for people with normal weight and one for people with higher weight who are already taking a GLP-1 injection for weight loss.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
This study tests a new medicine called PF-08653945 to see how it enters the blood in adults who are overweight or have obesity. The results will help doctors understand how the medicine works in the body.
This early-stage study tests a new experimental medicine (NNC0113-5840) to see how it works in people who are overweight or have obesity. Researchers want to understand how the body processes this medicine and whether it's safe before testing it more widely.
This trial tests a new medicine to see how the body handles it and whether it is safe. It is for healthy people, not for treating a disease, and helps researchers decide if the drug can move to the next stage of testing.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.